The $2 Billion Question Behind Kalshi’s New Prediction Market

Kalshi has introduced a new prediction market intended to accelerate drug development, though researchers warn it may bias funding toward perceived winners. Simultaneously, the company faces a court setback as Congress conducts hearings to grill sports prediction markets. These developments highlight the tension between Kalshi's goal of enhancing medical innovation and the regulatory challenges currently shaping the industry's legal landscape, as lawmakers scrutinize the operational frameworks of these emerging financial prediction platforms.